Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Revenue (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Revenue readings, the most recent being $5.1 billion for Q1 2026.

  • On a quarterly basis, Revenue rose 7.41% to $5.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $21.0 billion, a 5.97% increase, with the full-year FY2025 number at $20.6 billion, up 4.84% from a year prior.
  • Revenue hit $5.1 billion in Q1 2026 for GE HealthCare Technologies, down from $5.7 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $5.7 billion in Q4 2025 to a low of $4.3 billion in Q1 2022.
  • Median Revenue over the past 5 years was $4.8 billion (2024), compared with a mean of $4.9 billion.
  • Biggest five-year swings in Revenue: rose 8.38% in 2023 and later dropped 1.21% in 2024.
  • GE HealthCare Technologies' Revenue stood at $4.9 billion in 2022, then rose by 5.43% to $5.2 billion in 2023, then rose by 2.17% to $5.3 billion in 2024, then increased by 7.13% to $5.7 billion in 2025, then fell by 9.95% to $5.1 billion in 2026.
  • The last three reported values for Revenue were $5.1 billion (Q1 2026), $5.7 billion (Q4 2025), and $5.1 billion (Q3 2025) per Business Quant data.